Price target
34.100.000.00%
The 6 analysts offering 1 year price forecasts for CDTX have a max estimate of — and a min estimate of —.
Analyst rating
Based on 7 analysts giving stock ratings to CDTX in the past 3 months.
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
CDTX EPS for the last quarter is −1.47 CHF despite the estimation of −3.14 CHF. In the next quarter EPS is expected to reach −1.52 CHF. Track more of CIDARA THERAPEUTIC financials and stay on top of what is up with the company.
In the next quarter CIDARA THERAPEUTIC revenue is expected to reach 0.00 CHF. Check out CIDARA THERAPEUTIC revenue and earnings and make informed decisions.
According to analysts, CDTX price target is 34.10 CHF with a max estimate of 41.26 CHF and a min estimate of 28.88 CHF. Check if this forecast comes true in a year, meanwhile watch CIDARA THERAPEUTIC stock price chart and keep track of the current situation with CDTX news and stock market news.
We've gathered opinions of 7 analysts rating CDTX stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.